MHRA advice: Tibolone: benefit-risk balance (December 2014) (www.gov.uk).

TIBOLONE

Important: Therapy notes

Important: Formulation and dosage details

Formulation:

Tablets 2·5mg

Dosage:

For the short-term treatment of symptoms of oestrogen deficiency (including women being treated with gonadotrophin releasing hormone analogues (Other endocrine drugs)), 2·5mg daily.

Editorial Information

Document Id: F335